KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.43−0.40 (-10.44%)
Close on Nov 17, 2026Market cap $66.34MP/E –Yield –
Kala Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kala Bio's price to book ratio was 0.4× on Nov 11, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 0.4× to 7.7×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −7.3 |
| 2025 | Jul 31, 2025 | 7.7× | +3.0 |
| 2024 | Dec 31, 2024 | 4.7× | +3.0 |
| 2023 | Dec 29, 2023 | 1.7× | −0.9 |
| 2022 | Apr 29, 2022 | 2.6× | +1.3 |
| 2021 | Dec 31, 2021 | 1.3× | −2.3 |
| 2020 | Dec 31, 2020 | 3.6× | +0.6 |
| 2019 | Dec 31, 2019 | 3.0× | +0.8 |
| 2018 | Dec 31, 2018 | 2.2× | −2.4 |
| 2017 | Dec 29, 2017 | 4.6× | – |
See a number that looks wrong?